Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Reitz, C. & Mayeux, R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochemical pharmacology 88, 640–651,
https://doi.org/10.1016/j.bcp.2013.12.024
(2014).
2. Terry-Lorenzo, R. T. et al. Novel human D-amino acid oxidase inhibitors stabilize an active-site lid-open conformation. Biosci Rep 34,
https://doi.org/10.1042/BSR20140071
(2014).
3. Taavitsainen, P., Juvonen, R. & Pelkonen, O. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Drug Metab Dispos 29, 217–222 (2001).
4. Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO molecular medicine 8, 595–608,
https://doi.org/10.15252/emmm.201606210
(2016).
5. Karran, E., Mercken, M. & De Strooper, B. The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nature reviews. Drug discovery 10, 698–712,
https://doi.org/10.1038/nrd3505
(2011).
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献